4.47
Kezar Life Sciences Inc Aktie (KZR) Neueste Nachrichten
Is Kezar Life Sciences Inc. a good long term investmentOutstanding capital appreciation - Autocar Professional
What analysts say about Kezar Life Sciences Inc. stockRapid market gains - jammulinksnews.com
Kezar Life Sciences Inc. Stock Analysis and ForecastAccelerated capital growth - jammulinksnews.com
What drives Kezar Life Sciences Inc. stock priceAccelerated wealth expansion - jammulinksnews.com
When (KZR) Moves Investors should Listen - news.stocktradersdaily.com
How Kezar Life Sciences Inc. stock reacts to Fed policy changesBreakout Confirmation Tool - beatles.ru
Kezar Life Sciences’ (KZR) Neutral Rating Reiterated at HC Wainwright - Defense World
How high can Kezar Life Sciences Inc. stock price go in 2025Chart Based Entries - Newser
HC Wainwright & Co. Maintains Neutral Rating on Kezar Life Sciences - AInvest
In Brief: Kezar Plots Lupus Revival For Zetomipzomib As FDA Lifts Hold On Hepatitis Trial - insights.citeline.com
FDA Lifts Pause On Kezar's Liver Drug Trial—Next Stop Lupus Study - Benzinga
FDA lifts partial hold on Kezar’s zetomipzomib trial - The Pharma Letter
KZR: Kezar Life Sciences Maintains Neutral Rating by HC Wainwrig - GuruFocus
Kezar Says US FDA Lifts Partial Clinical Hold on Zetomipzomib Trial in Autoimmune Hepatitis; Shares Rise After Hours - MarketScreener
Kezar Life Sciences stock gains after FDA lifts partial clinical hold - Investing.com Canada
Organon & Co. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your RightsOGN - The Globe and Mail
Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis - Business Wire
What makes Kezar Life Sciences Inc. stock price move sharplyProven Trading Plan - Newser
Why Kezar Life Sciences Inc. stock attracts strong analyst attentionFree Predictions - Newser
How BPYPP stock performs during market volatilityExpert Trading Flow - Newser
How Kezar Life Sciences Inc. stock performs during market volatilityStrong Return Daily Alerts - Newser
Consensus Cloud Secures $225 Million Credit Facility - The Globe and Mail
How Li Bang International Corporation Inc. stock performs during market volatilitySwing Trade Signals - Newser
Where Will ARK 21Shares Bitcoin ETF Be in 5 Years? - The Globe and Mail
Bragg Gaming Expands U.S. Presence with Fanatics Casino Launch - The Globe and Mail
Where are the Opportunities in (KZR) - news.stocktradersdaily.com
SemiLEDs Reports Third Quarter Fiscal Year 2025 Financial Results - The Globe and Mail
Kezar Life Sciences (NASDAQ:KZR) Shares Up 2% – Time to Buy? - Defense World
(KZR) Proactive Strategies - news.stocktradersdaily.com
Kezar Life Sciences, Inc.(NasdaqCM: KZR) added to Russell Microcap Value Index - MarketScreener
Kezar Shareholders Re-Elect Board, Approve Pay Package in 2025 Vote | KZR SEC FilingForm 8-K - Stock Titan
Kezar Life Sciences, Inc. (NASDAQ:KZR) Shares Sold by Millennium Management LLC - Defense World
Two Sigma Investments LP Cuts Holdings in Kezar Life Sciences, Inc. (NASDAQ:KZR) - Defense World
(KZR) On The My Stocks Page - news.stocktradersdaily.com
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - The Manila Times
Northern Trust Corp Reduces Stock Position in Kezar Life Sciences, Inc. (NASDAQ:KZR) - Defense World
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference 2025 - BioSpace
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):